Actionable news
All posts from Actionable news
Actionable news in EXAS: EXACT Sciences Corporation,

Exact Sciences: Stock is Too Cheap

Exact Sciences Corporation (EXAS) looks stuck. Even after a 244 percent revenue increase on a 260 percent increase in Cologuard tests (to 40,000), the stock is not moving. That might change.

Growing commercial insurance coverage will help EXAS’s sales team convince physicians to adopt Cologuard. On its conference call, the company detailed the coverage in...